LAMEA Hypodermic Needles Market Size, Share & Industry Trends Analysis Report By Product (Safety and Non-safety), By Application, By End Users, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Hypodermic Needles Market
Market Report Description
The Latin America, Middle East and Africa Hypodermic Needles Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Patients with multiple sclerosis can also self-treat with injections. Certain MS medications, including interferon preparations, are developed to be self-administered via subcutaneous or intramuscular injection. Erectile dysfunction patients in some countries may be prescribed Alprostadil in injectable form, which is self-injected with a very thin hypodermic needle directly into the base or side of the penis.
Untrained users also utilize hypodermic needles for recreational intravenous drug usage. In many nations, hypodermic syringes were exclusively available by prescription before governments became aware of the spread of disease through sharing needles. Many countries operate needle exchange programs in large cities to reduce the spread of blood-borne infections like hepatitis as well as HIV, through shared injecting equipment. In certain nations, the government subsidizes such initiatives entirely or partially. Blunt needles, which lack a sharp bevel and are usually non-sterile, are used in industry to fill small containers or apply small amounts of solvent or adhesive precisely.
The prevalence of diabetes along with other related disorders is increasing in this region. Diabetes mellitus (DM) is one of the most common metabolic illnesses in the United Arab Emirates (UAE). The United Arab Emirates (UAE) has made remarkable progress in various sectors, including DM research, over the previous two decades. The current study illuminates the evolution of DM research in the UAE and serves as a framework for DM researchers to develop more targeted future paths in the field. Moreover, according to the National Library of Medicines, the population of the United Arab Emirates has been discovered to be particularly vulnerable to diabetes and its complications. In 2013, the UAE has one of the highest age-standardized comparative prevalence of diabetes in the world, at 18.98%, compared to 8.3% globally. According to the IDF, 17.3 % of the UAE's population in the age group of 20 and 79 had Type 2 diabetes in 2017. According to World Health Organization (WHO) reports on the DM profile in the UAE, 130 men and 100 women aged 30-69 years died from the disease in 2016.
The Brazil market dominated the LAMEA Hypodermic Needles Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $95.7 million by 2028. The Argentina market is experiencing a CAGR of 6.1% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 5.3% during (2022 - 2028).
Based on Product, the market is segmented into Safety and Non-safety. Based on Application, the market is segmented into Drug Delivery, Vaccination and Blood Specimen Collection. Based on End Users, the market is segmented into Hospital, Diabetic Patients, Family Practitioners, Psychiatry and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Hypodermic Needles Market is Predict to reach $4.2 Billion by 2028, at a CAGR of 3.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, Cardinal Health, Inc., B. Braun Melsungen AG, McKesson Corporation, Retractable Technologies, Inc., Connecticut Hypodermics, Inc., Exelint International, Co., and i-Tech Medics Private Limited.
Scope of the Study
Market Segments Covered in the Report:
- Safety and
- Drug Delivery
- Blood Specimen Collection
By End User
- Diabetic Patients
- Family Practitioners
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Terumo Corporation
- Nipro Corporation
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- McKesson Corporation
- Retractable Technologies, Inc.
- Connecticut Hypodermics, Inc.
- Exelint International, Co.
- Hi-Tech Medics Private Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free